Introduction Amino-acids positron emission tomography (PET) is increasingly used in the
diagnostic workup of patients with gliomas, including differential diagnosis, evaluation of …

Background: From the past decade to date, several studies related to O-(2-[18F] fluoroethyl)-
L-tyrosine (18F-FET) positron emission tomography (PET) in brain tumours have been …

This paper addresses issues of brain tumor, glioma, grading from multi-sensor images.
Different types of scanners (or sensors) like enhanced T1-MRI, T2-MRI and FLAIR, show …

Purpose The molecular features isocitrate dehydrogenase (IDH) mutation and 1p/19q co-
deletion have gained major importance for both glioma typing and prognosis and have …

Positron emission tomography (PET) imaging using amino acid tracers has in recent years
become widely used in the diagnosis and prediction of disease course in diffuse low-grade …

Background Glioma grading with dynamic 18 F-FET PET (0–40 min pi) is typically performed
by analysing the mean time-activity curve of the entire tumour or a suspicious area within a …

Purpose The aim of this study was to assess whether dynamic PET with 11 C-methionine
(MET)(MET-PET) is useful in the diagnosis of brain tumors. Methods One hundred sixty …

Introduction Aim was to develop a full automatic clustering approach of the time-activity
curves (TAC) from dynamic 18F-FET PET and evaluate its association with IDH1 mutation …

Abstract Purpose Dynamic 18 F-FET PET/CT is a powerful tool for the diagnosis of gliomas.
18 F-FET PET time–activity curves (TAC) allow differentiation between histological low …

Background The genetic status of 1p/19q is important for differentiating oligodendroglioma,
isocitrate‐dehydrogenase (IDH)‐mutant, and 1p/19q‐codeleted from diffuse astrocytoma …